News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Roche (RHHBY) Melanoma Drug Wins European Green Light



12/16/2011 8:34:59 AM

European regulators have recommended approval of a targeted melanoma drug from Swiss group Roche Holding AG, opening the way to a new treatment option for patients with the deadliest form of skin cancer. The green light for Zelboraf from the European Medicines Agency -- which Roche said on Friday it expected to be formally endorsed by the European Commission in February -- follows U.S. approval in August. The new drug is given as a twice-daily pill and is designed to be used alongside a companion diagnostic test, also from Roche, that identifies which patients have a specific genetic mutation that means they will benefit from the treatment.

Read at Reuters
Read at Bloomberg
Read at InPharm.com
Read at PharmaLive


comments powered by Disqus
Roche
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES